Teva Aims To Revoke Rival's Blood Transfusion Drug Patent
Generic drugs manufacturer Teva has taken Novartis AG to court in a bid to invalidate two of the pharmaceutical giant's patents for a blood transfusion medicine, arguing that its rival's claimed...To view the full article, register now.
Already a subscriber? Click here to view full article